eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2021, Volume 17, Issue 2 : 35-38
Research Article
Impact of Emergency PCI Protocols During Off-Hours: A Clinical Outcome Analysis
 ,
 ,
 ,
1
Department of Interventional Cardiology, Metro Heart Institute, New Delhi, India
2
Department of Emergency Medicine, Guwahati Medical College & Hospital, Assam, India
3
Institute of Cardiac Sciences, Bangalore Medical Research Center, Karnataka, India
4
School of Public Health, University of Mumbai, Maharashtra, India
Received
Aug. 18, 2021
Revised
Sept. 29, 2021
Accepted
Nov. 11, 2021
Published
Dec. 21, 2021
Abstract

Timely reperfusion through primary percutaneous coronary intervention (PCI) is the gold standard treatment for ST-elevation myocardial infarction (STEMI). However, delays during off-hours—nights, weekends, and public holidays—may influence door-to-balloon (DTB) time, resource availability, and clinical outcomes. This study evaluates the impact of emergency PCI protocols during off-hours in a tertiary care system over 14 months, comparing procedural efficiency, mortality, and major adverse cardiac events (MACE) between regular-hours and off-hours presentations. A total of 246 patients were enrolled (110 during regular hours, 136 during off-hours). Results indicate a statistically significant increase in DTB time during off-hours (median 82 min vs 64 min) and slightly higher 30-day mortality (7.3% vs 4.5%). However, structured off-hours activation protocols reduced delays by 23% compared to the historical baseline. Findings suggest off-hours PCI can achieve comparable outcomes when optimized through rapid team activation models.

 

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Personalized Healthcare Using Genomic Data: Advancing Precision Medicine Through Genomic Innovation
51-55
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
Mental Health Awareness and Help-Seeking Behavior: A Comprehensive Study of Knowledge, Attitudes, Barriers, and Interventions
7-12
Community-Based Health Programs and Their Effectiveness: Evaluating Impacts on Population Health Outcomes
13-19
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.